PharmaNet aims to put bad times behind it with expansion

By Nick Taylor

- Last updated on GMT

Related tags Latin america São paulo

Despite going through a difficult period PharmaNet is continuing to expand through the opening of another office in Latin America, which reinforces its commitment to the region.

The office in Sao Paulo, Brazil is the contract research organisation’s (CRO) second in Latin America, following the opening of a site in Buenos Aires, Argentina in 2003.

These two sites complement the network of field staff it has in Peru and Mexico, which gives it a presence in many of the attractive clinical trial locations in Latin America.

The four countries PharmaNet is active in are, together with Colombia and Chile, the hotspots for the regions clinical trials and account for around 80 per cent of population.

A large population, which is concentrated into some very big cities, is one factor attracting CROs to the region, with the US time zone among other benefits of operating their.

Fernanda Duran, executive director, Latin American operations, said: "The number of clinical trials in Latin America has experienced significant growth over the past ten years​.

"Our clients are more actively requesting Latin American sites in order to meet aggressive timelines for patient recruitment, thus bringing their new drugs to market sooner. I am thrilled about opening this office in Brazil which will enhance our infrastructure in the region​."

This upbeat expansion comes shortly after PharmaNet was acquired by a private equity buyer, a move which it hopes will mark the end of a challenging time in the company’s life.

A spate of cancelled and delayed contracts led to disappointed financial results and the share price dropping from a 52 week high of $42 to just $0.68. The acquisition has resulted in a slight rise to $4.95 but this still falls a long way short of the giddy heights reached a year ago.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more